InvestorsHub Logo
Followers 87
Posts 5742
Boards Moderated 0
Alias Born 03/07/2014

Re: Rkmatters post# 16304

Wednesday, 05/18/2016 1:23:52 PM

Wednesday, May 18, 2016 1:23:52 PM

Post# of 34608
Hi Regina. That would be incredible for the company to be able to get two vaccines to market from Fra especially the patient specific. Hoping for great results from the combo study. That would be very positive. Hopefully they'll get to run another trial with the dendritic cell version. Do you think they have treated any of the recruited patients yet? That would be a positive news event if they started treatment. I always see companies announce when they begin treatment.
Let's hope they are at least close to that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News